An alternative view sees GD as a dimensional construct, with individuals demonstrating varying degrees of GD feelings that can be measured using continuous self-reported measures [12, 14, 44]
The center will cost about $6 million to build
Cognitive-behavioral therapy Drug therapy: First-line antidepressants, including selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine [Prozac] and sertraline [Zoloft]) and serotonin-norepinephrine reuptake inhibitors (SNRIs) (eg, duloxetine [Cymbalta] and venlafaxine [Effexor]) Second-line antidepressants, including tricyclic antidepressants (TCAs) (eg, amitriptyline [Elavil] and clomipramine [Anafranil]) and monoamine oxidase inhibitors (MAOIs) (eg, tranylcypromine [Parnate] and phenelzine [Nardil]) Other antidepressants, including mirtazapine (Remeron), trazadone (Desyrel), vilazodone (Viibryd), and vortioxetine (Trintellix) Benzodiazepines such as diazepam (Valium), alprazolam (Xanax), and clonazepam (Klonopin) Buspirone (BuSpar) Hydroxyzine (Vistaril, Atarax) Pregabalin (Lyrica), an anticonvulsant drug that is also effective in treating anxiety Quetiapine (Seroquel), an antipsychotic drug that is also effective in reducing symptoms of anxiety What are Some Emerging Treatments for Anxiety Disorders
Vitix depigmentation regulating gel is applied 1 to 2 times a day to depigmented areas and their surroundings, over a period of 4 to 6 months
R., Luizon, M
